Ardelyx reported $208.26M in Debt for its fiscal quarter ending in March of 2026.





Debt Change Date
Abbott USD 34.05B 20.19B Mar/2026
Amgen USD 54.6B 17M Dec/2025
Ardelyx USD 208.26M 653K Mar/2026
aTyr Pharma USD 1.81M 29K Mar/2026
Corcept Therapeutics USD 6.11M 251K Dec/2025
Curis USD 0 0 Jun/2022
Sanofi EUR 20.02B 1.73B Mar/2026
TG Therapeutics USD 253.71M 8.37M Dec/2025
United Therapeutics USD 200M 100M Mar/2025